Host Response Diagnostics

Delivering precision medicine on demand


TEDx Palo Alto:
The power of reading the immune system to better diagnose disease

Dr. Tim Sweeney, Inflammatix Co-Founder and CEO

Our tests are addressing significant clinical needs in acute infection and sepsis diagnosis that affect millions of people


In the News: Game Changing Impact

Recent notable news stories

December 15, 2020

A Bright Future Ahead for Novel Markers of Infection

Link to story

October 29, 2020

Inflammatix Awarded $7.4M in Additional BARDA Funding for POC System, Acute Infection Test

Link to Story

October 8, 2020

Inflammatix Moving Into Coronavirus Test Market With Gene Expression Host Response Platform

Link to story

September 30, 2020

Machine Learning-Based Rapid Diagnostic Reads Immune System to Predict COVID-19 Severity Risk

Link to story

Also covered by


Stay in touch with social updates: Find out the latest news.

Follow us on Twitter
Follow us on LinkedIn